Peptides Semaglutide 2mg CAS:910463-68-2

Peptides Semaglutide 2mg CAS:910463-68-2
Product Introduction:
Semaglutide (semaglutide/semaglutide) is a new, long-acting glucagon-like peptide-1 (GLP-1) analog developed by Denmark's Novo Nordisk. It is also the world's third-largest A long-acting GLP-1 week preparation. It is a long-acting dosage form developed based on the basic structure of liraglutide. It is mainly used to treat type 2 diabetes. It has multiple functions such as lowering blood sugar, losing weight, improving insulin resistance, and reducing cardiovascular risk. Semaglutide effectively lowers blood sugar levels by stimulating GLP-1 receptors, promoting insulin secretion while inhibiting glucagon secretion. In addition, it can suppress appetite and prolong the feeling of fullness, helping patients reduce food intake and achieve weight loss. In clinical application, Semaglutide has performed well. Compared with traditional antidiabetic drugs such as metformin, Semaglutide has a more significant antihyperglycemic effect, can more effectively reduce glycated hemoglobin (HbA1c) levels, and can better control postprandial blood sugar.
Send Inquiry
Description
Technical Parameters

  ↵

Product Introduction

Name:Semaglutide

Product Benefits:Weight management and weight loss

CAS:910463-68-2

Capacity:2mg/vial

Product Form:White or off-white powder(Peptides)

Shelf Life:2-3Years(The product packaging date shall prevail)

What is Semaglutide?

 

Semaglutide is a drug used to treat type 2 diabetes and obesity. It belongs to a class of drugs called Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA). It promotes insulin secretion, suppresses appetite, slows gastric emptying, and improves glucose metabolism by mimicking the GLP-1 hormone naturally present in the human body. Semaglutide was developed by Novo Nordisk of Denmark and is marketed under trade names such as **Ozempic** (for diabetes) and **Wegovy** (for obesity).

 

### Physical and chemical properties:

Semaglutide is a synthetic peptide molecule that mimics the GLP-1 hormone in the human body. Its molecular structure is similar to the amino acid sequence of natural GLP-1, but it has undergone several chemical modifications to give it a longer half-life and enhanced stability.

1. **Molecular formula**: C187H291N45O59

2. **Molecular weight**: 4112.67 Da

3. **Chemical structure**: The structure of Semaglutide is based on the natural peptide chain of GLP-1, but by replacing some amino acids and adding fatty acid chains (to enable it to bind to plasma proteins), its duration of action is prolonged.

4. **Dosage**: Usually subcutaneous injection (SC), can be self-injected, common dosage forms include pre-filled injection pens.

 

### Main mechanism of action:

Semaglutide plays the following roles by mimicking the effects of GLP-1:

1. **Promoting insulin secretion**: Semaglutide stimulates pancreatic β cells to secrete insulin when blood sugar rises, helping to lower blood sugar levels.

2. **Inhibiting glucagon secretion**: When blood sugar is too high, Semaglutide further reduces sugar production by inhibiting pancreatic α cells from secreting glucagon.

3. **Delaying gastric emptying**: Semaglutide can slow down the emptying time of the stomach, allowing gastric contents to stay in the stomach longer, thereby reducing appetite and helping to lose weight.

4. **Improving insulin sensitivity**: Semaglutide helps improve insulin resistance and promote the utilization of sugar.

 

### Dosage and use:

The dose of Semaglutide depends on the treatment goal (diabetes or obesity) and the patient's response. Usually, the dose needs to be gradually increased at the beginning of treatment to reduce side effects.

1. **For diabetes (Ozempic)**:

- Initial dose: 0.25 mg/week (1 month)

- Maintenance dose: 0.5 mg/week (usually increased to 0.5 mg/week after 1 month), up to 1 mg/week.

- Injection method: subcutaneous injection, once a week.

2. **For obesity (Wegovy)**:

- Initial dose: 0.25 mg/week (1 month)

- Gradual increase in dose: Increase the dose every 4 weeks, eventually up to 2.4 mg/week.

- Maintenance dose: 2.4 mg/week.

- Injection route: Subcutaneous injection, once a week.

 

### Half-life and pharmacokinetics:

Semaglutide has a long half-life, which is a significant advantage, allowing it to be injected only once a week instead of every day. Its pharmacokinetic characteristics are as follows:

1. **Half-life**: About **1 week (about 1 week)**, which is also an important difference from the natural GLP-1 hormone, which has a very short half-life (about 2 minutes).

2. **Peak concentration**: The highest concentration in plasma is reached about **1-3 days** after injection.

3. **Bioavailability**: The bioavailability after subcutaneous injection is high, usually about 89%.

4. **Drug metabolism**: Semaglutide is mainly metabolized by the liver, but unlike many small molecule drugs that undergo significant liver enzyme metabolism, it is mainly degraded by proteases.

 

### Action period:

Semaglutide has a longer duration of action because it has a long half-life in the body. Normally, the effect of Semaglutide gradually appears after injection, and the blood concentration remains high in the next few days. Its main effects are:

1. **Glucose control**: Usually within a few days, it starts to effectively lower blood sugar and continuously improves sugar metabolism.

2. **Weight loss**: Weight loss usually takes several weeks to months to appear, gradually improving appetite and increasing satiety.

 

### Common side effects:

Semaglutide, as part of the GLP-1 receptor agonist, may cause some side effects, especially gastrointestinal symptoms. Common side effects include:

1. **Nausea**: Especially common in the early stages of treatment or when the dose is increased.

2. **Vomiting**, **Diarrhea**: Some patients may experience indigestion.

3. **Loss of appetite**: Due to delayed gastric emptying, patients may feel full for a longer period of time.

4. **Hypoglycemia**: May occur when used in combination with other hypoglycemic drugs (such as insulin, sulfonylurea drugs).

5. **Injection site reaction**: Local redness, swelling or pain.

 

### Contraindications and precautions:

- **Risk of thyroid cancer**: Semaglutide has been shown to be associated with the development of thyroid cancer in animal studies, so patients with thyroid diseases (such as familial thyroid cancer or multiple endocrine neoplasia) should not use it.

- **Pancreatitis**: Patients with a history of acute pancreatitis should use it with caution.

- **Pregnant and lactating women**: There is limited data on its use during pregnancy and lactation, and it is generally recommended to avoid use unless necessary.

- **Liver and kidney dysfunction**: Patients with liver or kidney disease need to adjust their use according to the doctor's advice.

 

### Summary:

Semaglutide is a highly effective GLP-1 receptor agonist that helps control type 2 diabetes and obesity through multiple mechanisms such as promoting insulin secretion, suppressing appetite, slowing gastric emptying, and improving glucose metabolism. Its long half-life makes it possible to inject once a week, increasing patient compliance. However, some side effects need to be paid attention to when using it, especially gastrointestinal reactions and the risk of hypoglycemia. It should be used with caution for pregnant women, lactating women and patients with thyroid diseases.

18

 

Who should use Semaglutide?

 

Semaglutide is a drug used to treat type 2 diabetes and obesity. It belongs to the class of drugs called GLP-1 (glucagon-like peptide-1) receptor agonists. GLP-1 is a natural intestinal hormone that helps regulate blood sugar levels and appetite.

 

### 1. **Applicable population**

Semaglutide is suitable for the following types of patients:

- **Type 2 diabetes patients**: used for blood sugar control, especially for patients who are dissatisfied with oral hypoglycemic drug treatment or cannot control blood sugar.

- **Obese patients**: Semaglutide has been approved for weight management for obese adult patients with weight management needs, including those with weight-related health problems (such as high blood pressure, type 2 diabetes, etc.).

 

### 2. **How ​​it works**

Semaglutide mimics the effects of GLP-1 and controls blood sugar and weight through the following mechanisms:

- **Stimulate insulin secretion**: Semaglutide promotes the secretion of insulin from the pancreas when blood sugar levels rise, thereby helping to lower blood sugar.

- **Inhibits glucagon secretion**: It also reduces the secretion of glucagon by the pancreas, a hormone that promotes the release of glucose by the liver, so it lowers blood sugar by reducing the release of glucose by the liver.

- **Delays gastric emptying**: Semaglutide can slow down the emptying of the stomach and prolong the time that food stays in the stomach, thereby helping to increase satiety and reduce food intake.

- **Improves insulin sensitivity**: Long-term use of Semaglutide helps to increase the body's sensitivity to insulin and further improve blood sugar control.

 

### 3. **Dosage**

Semaglutide generally has two common ways of administration: **subcutaneous injection** and **oral**. The specific dosage is as follows:

#### Subcutaneous injection (common form of treatment)

- **Dose initiation**: Usually starts with 0.25 mg/week, injected once a week for 4 weeks, with the aim of gradually adapting to the drug.

- **Dose increase**: The dose can then be increased, usually to 0.5 mg/week after 4 weeks.

- **Maximum recommended dose**: If a stronger blood sugar lowering effect is required, the dose can be further increased to 1 mg/week, with a maximum dose of 2 mg/week. Specific dose adjustments should be made according to the doctor's advice.

- **Injection site**: Semaglutide injection sites include thighs, abdomen or upper arms, and rotate sites to avoid skin irritation.

#### Oral dosage form

- **Dosage**: The recommended starting dose of Semaglutide oral dosage form is 3 mg/day, which is increased to 7 mg/day after 4 weeks, and then increased to 14 mg/day based on blood sugar control.

- **Dosage method**: It should be taken at least 30 minutes before breakfast, and it should not be taken with food, drinks or other drugs. Avoid eating for at least 30 minutes after taking the medicine.

 

### 4. **Common side effects**

Common side effects of Semaglutide include:

- **Gastrointestinal discomfort**: Such as nausea, vomiting, diarrhea or constipation. These side effects are usually more obvious in the early stage of medication and will be alleviated as the body adapts to the medication.

- **Hypoglycemia**: Although Semaglutide itself is unlikely to cause hypoglycemia, it may increase the risk of hypoglycemia when used in combination with other glucose-lowering drugs.

- **Injection site reactions**: For example, redness, swelling or pain.

- **Pancreatitis**: Although rare, Semaglutide may cause the risk of pancreatitis. If severe abdominal pain occurs, seek medical attention immediately.

 

### 5. **Contraindications and precautions**

- **Pregnant and breastfeeding women**: The safety of Semaglutide in pregnant women has not yet been determined. It should be used with caution and should be avoided by pregnant or breastfeeding women.

- **Thyroid tumors**: Semaglutide may be associated with the risk of certain thyroid tumors (such as medullary thyroid cancer), so it is contraindicated in patients with this history.

- **Severe renal insufficiency**: Semaglutide should be used with caution in patients with severe renal insufficiency.

13

 

Advantages of Semaglutide

 

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk. It was originally used to treat type 2 diabetes and was later approved. For weight management. As an insulin-like drug, semaglutide brings a range of health benefits by mimicking the effects of GLP-1 to enhance insulin secretion and inhibit gastric emptying. Here are the main benefits of Semaglutide:

 

### 1. **Help control blood sugar (for type 2 diabetes)**

Semaglutide helps control postprandial and fasting blood sugar by stimulating pancreatic beta cells to secrete insulin and inhibiting glucagon secretion when blood sugar levels rise. Due to its mechanism of action, semaglutide can lower patients' blood sugar levels, relieve diabetes symptoms, and help improve long-term blood sugar control (by lowering HbA1c levels).

- **Effectively reduces HbA1c**: Semaglutide can significantly reduce HbA1c levels in patients with type 2 diabetes. HbA1c is an indicator of long-term blood sugar control.

- **Postprandial Blood Sugar Regulation**: Semaglutide can reduce postprandial blood sugar surges, especially those after carbohydrate-rich meals.

 

### 2. **Weight management and weight loss**

Semaglutide has been widely used in the treatment of type 2 diabetes, but its effectiveness in weight management has also attracted widespread attention. By inhibiting gastric emptying and enhancing satiety, Semaglutide can effectively help patients reduce appetite, thereby reducing calorie intake and achieving weight loss.

- **Appetite reduction and eating control**: Semaglutide helps suppress appetite by acting on the appetite regulation center of the brain, making it easier for people to control their diet.

- **Weight Loss**: Clinical trials have shown that Semaglutide can significantly promote weight loss. For non-diabetic patients, the weight loss effect of Semaglutide injection is obvious, especially for obese or overweight patients.

**Semaglutide for Obesity Treatment**: The weight-loss effects of semaglutide led to its approval as a weight-loss drug in non-diabetic patients. Semaglutide has been shown to be an effective weight loss drug for people with a body mass index (BMI) over 30.

 

### 3. **Improve cardiovascular health**

Studies have found semaglutide has potential in reducing cardiovascular risk, particularly in patients with diabetes.

- **Reduce the risk of cardiovascular events**: Clinical trial data show that Semaglutide can significantly reduce the incidence of cardiovascular events in patients with cardiovascular diseases, including heart disease, heart failure and stroke.

- **Improves blood pressure and cholesterol levels**: Semaglutide can also have a slight lowering effect on blood pressure, especially in patients with high blood pressure. In addition, it can improve some lipid markers related to cardiovascular health, such as lowering low-density lipoprotein cholesterol (LDL) and increasing high-density lipoprotein cholesterol (HDL).

 

### 4. **Improve Liver Health**

Semaglutide also has certain benefits for patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Studies show that semaglutide can improve liver health by reducing liver fat accumulation and liver inflammation.

- **Reduce Fatty Liver**: Semaglutide can reduce fat accumulation in the liver and help relieve NAFLD.

- **Improve liver inflammation**: In some clinical studies, Semaglutide has also shown positive effects on NASH, reducing liver inflammation and improving liver function.

 

### 5. **Potential to fight cancer**

Although the anti-cancer effect of semaglutide is still in the research stage, there is preliminary evidence that it may have anti-tumor effects. GLP-1 receptor agonists are believed to have a certain inhibitory effect on certain types of cancer by regulating insulin secretion, reducing inflammatory responses, and improving fat metabolism.

 

### 6. **Improve Metabolic Health**

In addition to diabetes and weight management, Semaglutide also has a positive impact on overall metabolic health. By improving insulin sensitivity and reducing body fat proportions, Semaglutide helps maintain or increase metabolic rate, thereby having beneficial effects on health problems such as metabolic syndrome and insulin resistance.

- **Increase insulin sensitivity**: Semaglutide can increase the body's sensitivity to insulin, improve glucose metabolism, and reduce insulin resistance.

 

### 7. **Improved gastrointestinal health**

Since one of Semaglutide's mechanisms of action is to delay gastric emptying, it can help improve the digestive process and increase the feeling of fullness. Patients with gastrointestinal irritation often report that semaglutide causes them to eat less, thereby reducing gastrointestinal burden.

 

### 8. **Safety and Side Effects**

Semaglutide is a relatively safe drug, but like many drugs, it can cause some side effects. Common side effects include nausea, vomiting, diarrhea, or constipation, especially when starting treatment. These side effects usually decrease over time. Patients are usually advised to start with a lower dose and gradually increase it.

 

### Summarize:

As a GLP-1 receptor agonist, Semaglutide can not only effectively control blood sugar and improve weight, but also have a positive impact on cardiovascular health, liver function, metabolic health and other aspects. Its weight loss effect is particularly significant and it has been widely used in the treatment of obesity. In addition, the long-term safety and further potential benefits of semaglutide are still being actively studied, and it is expected to become an important tool in the management of diabetes, obesity and related diseases.

6

 

Contact Details(WhatsApp  Telegram ) And Payment Methods

 

WhatsApp/Telegram:+852 6749 2648

Gmail:lucasraws207@gmail.com

Skype:live:.cid.8f21dc7fc6621ba7

1729737702523 1729737641865 product-570-257

 

FAQ

Q: What is the mechanism of action of Semaglutide?

A: Semaglutide binds to the GLP-1 receptor and exerts the following effects:
- **Promoting insulin secretion**: After a meal, Semaglutide can help increase insulin secretion and help lower blood sugar levels.
- **Inhibiting glucagon secretion**: Semaglutide can inhibit the secretion of glucagon, which helps reduce the amount of glucose produced by the liver.
- **Slowing gastric emptying**: It slows down the emptying of gastric contents, prolongs the feeling of fullness after a meal, and reduces food intake.
- **Reducing appetite**: Semaglutide helps reduce hunger and appetite by affecting the appetite regulation area of ​​the central nervous system.

Q: What are the clinical uses of Semaglutide?

A: Semaglutide is mainly used in the following two aspects:
1. **Treatment of type 2 diabetes**: Semaglutide helps control blood sugar and improve insulin resistance to a certain extent.
2. **Weight management**: As a weight loss drug, Semaglutide helps reduce weight and is suitable for obese or overweight patients who need to lose weight, especially in patients with diabetes or cardiovascular disease.

Q: What are the side effects of Semaglutide? 

A: Side effects of Semaglutide may include:
- **Gastrointestinal discomfort**: such as nausea, vomiting, diarrhea, abdominal pain, etc., especially in the early stage of drug use.
- **Hypoglycemia**: When used in combination with other glucose-lowering drugs (such as sulfonylureas or insulin), it may cause hypoglycemia.
- **Headache, fatigue**: Some patients may experience headache or fatigue.
- **Pancreatic problems**: Although rare, Semaglutide may raise the risk of pancreatitis.
- **Allergic reactions**: In rare cases, patients may experience an allergic reaction to Semaglutide, such as rash, difficulty breathing, etc.

 

Hot Tags: peptides semaglutide 2mg cas:910463-68-2, China peptides semaglutide 2mg cas:910463-68-2 manufacturers, suppliers, factory, Follistatin 344 and Fst 344, PT141 CAS 32780 32 8, AOD9604 No effect on blood sugar and growth, PEG MGF Accelerate recovery and improve training effect, GDF 8 Muscles are firmer and more defined, Ipamorelin Protect muscle tissue

Send Inquiry
Auctus Steroid Pharma Co., Ltd
Provide a complete after-sales service guarantee, including product return and exchange policies, quality assurance, etc.
contact us